封面
市場調查報告書
商品編碼
1678766

日本數位醫療市場 - 2025-2033

Japan Digital Health Market - 2025-2033

出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年日本數位健康市場規模達到 109.6 億美元,預計到 2033 年將達到 5,142 萬美元,2025-2033 年預測期內的複合年成長率為 19.0%。

數位健康是指利用數位科技改善醫療服務、增強健康效果並促進病患的整體健康。這個快速發展的領域將行動應用程式、穿戴式裝置、人工智慧 (AI)、遠距醫療和電子健康記錄 (EHR) 等技術融入醫療保健的各個方面。目標是提高護理的效率、可及性和質量,使醫療服務更加個人化、及時性和有效。

數位健康解決方案有助於更好地協調各個醫療保健提供者之間的護理,改善患者體驗並減少分散的護理。隨著科技的不斷發展,數位醫療可望進一步徹底改變醫療保健的提供方式,提供更便利、更有效率、以病人為中心的服務。

市場動態:

促進因素與約束因素

老年人口不斷增加

日本人口老化是數位健康市場的主要驅動力,因為慢性病發病率較高以及長期照護的需求導致對醫療保健服務的需求增加。遠距醫療、遠端監控、穿戴式裝置和人工智慧工具等數位健康解決方案對於應對這些挑戰至關重要,因為它們使老年人能夠遠端獲得護理、即時追蹤重要健康指標並更有效地管理慢性病。

這些技術不僅提供個人化的護理,而且還減輕了醫療保健提供者的負擔,特別是在專業人員短缺的農村地區。此外,輔助機器人和智慧家居解決方案等創新正在改善老年人的日常生活。在政府透過「醫療政策2025」等措施的支持下,數位健康解決方案擴大融入日本的醫療保健體系,確保老年人能夠得到所需的護理,同時提高整體醫療保健的效率和可及性。

技術限制

預計技術限制將在多個方面嚴重阻礙日本數位健康市場的成長。儘管日本擁有強大的技術基礎設施,但醫療保健系統之間互通性不足、軟體過時以及缺乏標準化資料格式等挑戰可能會限制數位健康解決方案的無縫整合。

目錄

第 1 章:方法與範圍

第 2 章:定義與概述

第 3 章:執行摘要

第 4 章:動態

  • 影響因素
    • 驅動程式
      • 老年人口不斷增加
      • 家庭醫療保健擴大採用先進技術
    • 限制
      • 技術限制
      • 資料隱私問題
    • 機會
      • 市場參與者的策略主動性不斷增強
  • 影響分析

第5章:戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析:最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 6 章:按組件

  • 硬體
  • 軟體
  • 服務

第 7 章:按類型

  • 行動醫療
  • 電子健康
  • 遠距醫療
  • 健康分析
  • 其他

第 8 章:按最終用戶

  • 醫療保健提供者
  • 醫療保健消費者
  • 其他

第9章:競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第10章:公司簡介

  • OMRON Corporation
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 主要進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • CureApp
  • Shionogi & Co., Ltd.
  • HealthNode
  • Whill
  • Allm Inc.
  • Dai-ichi Life Holdings, Inc.
  • Xiaomi
  • Hitachi Energy Ltd.
  • Similar data will be provided for each market player.

第 11 章:附錄

簡介目錄
Product Code: HCIT9209

The Japan digital health market reached US$ 10.96 billion in 2024 and is expected to reach US$ 51.42 million by 2033, growing at a CAGR of 19.0% during the forecast period of 2025-2033.

Digital health refers to using digital technologies to improve healthcare delivery, enhance health outcomes, and promote a patient's overall well-being. This rapidly growing field integrates technology such as mobile apps, wearables, artificial intelligence (AI), telemedicine, and electronic health records (EHRs) into various aspects of healthcare. The objective is to enhance the efficiency, accessibility, and quality of care, making healthcare services more personalized, timely, and effective.

Digital health solutions facilitate better coordination of care across various healthcare providers, improving patient experiences and reducing fragmented care. As technology continues to evolve, digital health is expected to further revolutionize how healthcare is delivered, offering more accessible, efficient, and patient-centered services.

Market Dynamics: Drivers & Restraints

Rising Geriatric Population

Japan's aging population is a key driver of the digital health market, as the demand for healthcare services increases due to the higher prevalence of chronic diseases and the need for long-term care. Digital health solutions, such as telemedicine, remote monitoring, wearables, and AI-driven tools, are essential in addressing these challenges by enabling elderly individuals to access care remotely, track vital health metrics in real time, and manage chronic conditions more effectively.

These technologies not only provide personalized care but also reduce the burden on healthcare providers, particularly in rural areas where there is a shortage of professionals. Additionally, innovations like assistive robots and smart home solutions are improving the daily lives of elderly people. With government support through initiatives like the "Healthcare Policy 2025," digital health solutions are increasingly integrated into Japan's healthcare system, ensuring that elderly citizens can receive the care they need while improving overall healthcare efficiency and accessibility.

Technical Limitations

Technical limitations are expected to significantly hinder the growth of Japan's digital health market in several ways. Despite Japan's strong technological infrastructure, challenges such as insufficient interoperability between healthcare systems, outdated software, and lack of standardized data formats can limit the seamless integration of digital health solutions.

Segment Analysis

The Japan digital health market is segmented based on component, type, and end-user.

Type:

mHealth in the type segment is expected to dominate in the Japan digital health market.

Japan has a high smartphone penetration rate and a tech-savvy population, making mobile health applications and services highly accessible and widely adopted. The aging population, in particular, is a major driver for mHealth solutions, as mobile apps and wearables can help older adults monitor their health, track vital signs, and manage chronic conditions without requiring frequent visits to healthcare providers.

mHealth solutions, such as health tracking apps, medication reminders, and telemedicine platforms, offer convenience and flexibility for patients, empowering them to take charge of their health. Moreover, Japan's focus on preventative care and wellness aligns with the growing use of mHealth tools that promote healthier lifestyles, encourage regular physical activity, and track diet and sleep. As more healthcare providers and patients embrace mobile solutions for daily health management, the mHealth segment is expected to lead Japan's digital health market growth by offering efficient, accessible, and personalized healthcare options.

Competitive Landscape

The major players in Japan digital health market include Takeda Pharmaceutical Company Limited, OMRON Corporation, CureApp, Shionogi & Co., Ltd., HealthNode, Whill, Allm Inc., Dai-ichi Life Holdings, Inc., Xiaomi, and Hitachi Energy Ltd., among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan Digital Health Market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Component
  • 3.2. Snippet by Type
  • 3.3. Snippet by End-User

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Geriatric Population
      • 4.1.1.2. Increasing Adoption of Advanced Technologies in Home Healthcare
    • 4.1.2. Restraints
      • 4.1.2.1. Technical Limitations
      • 4.1.2.2. Data Privacy Concerns
    • 4.1.3. Opportunity
      • 4.1.3.1. Increasing Strategic Initiatives by Market Players
  • 4.2. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
  • 5.6. Porter's Five Forces Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Component

  • 6.1. Introduction
    • 6.1.1. Analysis and Y-o-Y Growth Analysis (%), By Component
    • 6.1.2. Market Attractiveness Index, By Component
  • 6.2. Hardware*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Software
  • 6.4. Services

7. By Type

  • 7.1. Introduction
    • 7.1.1. Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2. Market Attractiveness Index, By Type
  • 7.2. mHealth*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. eHealth
  • 7.4. Telehealthcare
  • 7.5. Health Analytics
  • 7.6. Others

8. By End-User

  • 8.1. Introduction
    • 8.1.1. Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.1.2. Market Attractiveness Index, By End-User
  • 8.2. Healthcare Providers*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Healthcare Consumers
  • 8.4. Others

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

Key Market Players

  • 10.1. OMRON Corporation*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio
      • 10.1.2.1. Product Description
      • 10.1.2.2. Product Key Performance Indicators (KPIs)
      • 10.1.2.3. Historic and Forecasted Product Sales
    • 10.1.3. Financial Overview
      • 10.1.3.1. Company Revenue's
      • 10.1.3.2. Geographical Revenue Shares
      • 10.1.3.3. Revenue Forecasts
    • 10.1.4. Key Developments
      • 10.1.4.1. Mergers & Acquisitions
      • 10.1.4.2. Key Product Development Activities
      • 10.1.4.3. Regulatory Approvals, etc.
    • 10.1.5. SWOT Analysis
  • 10.2. CureApp
  • 10.3. Shionogi & Co., Ltd.
  • 10.4. HealthNode
  • 10.5. Whill
  • 10.6. Allm Inc.
  • 10.7. Dai-ichi Life Holdings, Inc.
  • 10.8. Xiaomi
  • 10.9. Hitachi Energy Ltd.
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us